idelalisab

You Shouldn't Ignore Gilead's Idelalisib
Motley Fool
Thu, 10/17/13 - 09:54 am
Gilead
idelalisab
indolent non-Hodgkin's lymphoma
ASCO '13 Preview: Gilead's Big Cancer Debut
TheStreet.com
Thu, 05/16/13 - 08:54 am
Gilead
ASCO
JNJ
Pharmacyclics
idelalisab
ibrutinib
CLL